OAM
TMDX icon

Ophir Asset Management’s Transmedics TMDX Stock Holding History

Ophir Asset Management’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-174,407
Closed -$13.8M – 40
2023
Q4 		$13.8M Sell
174,407
-121,354
-41% -$7.32M 2.73% 20
2023
Q3 		$16.2M Sell
295,761
-122,605
-29% -$8.83M 3.82% 16
2023
Q2 		$35.1M Buy
418,366
+172,949
+70% +$13.2M 7.32% 1
2023
Q1 		$18.6M Sell
245,417
-256,809
-51% -$17.8M 3.46% 14
2022
Q4 		$31M Buy
502,226
+122,634
+32% +$6.52M 5.96% 2
2022
Q3 		$15.8M Buy
+379,592
New +$16.5M 2.89% 19

Other funds holding TMDX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ophir Asset Management's TMDX Position: Q1 2024 in Review

Ophir Asset Management sold out of Transmedics (TMDX) in Q1 2024, closing a stake of 174,407 shares — an estimated $13.8M sold.

Ophir Asset Management first reported a position in TMDX in Q3 2022 and held it in 6 quarters. The position peaked at $35.1M in Q2 2023. 263 funds tracked by Wall St. Rank hold TMDX as of Q1 2024.

  • Ophir Asset Management reported no remaining Transmedics position as of Q1 2024 after selling out during the quarter.
  • Ophir Asset Management sold 174,407 Transmedics shares in Q1 2024, an estimated $13.8M.
  • Ophir Asset Management first reported a position in Transmedics in Q3 2022 and held it in 6 quarters.
  • Ophir Asset Management's Transmedics position peaked at $35.1M in Q2 2023.
  • 263 funds tracked by Wall St. Rank held Transmedics as of Q1 2024.

Based on Ophir Asset Management's 13F filing for Q1 2024, filed 15 May 2024.